Abstract # 1121 A Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy in Combination with ZD1839 (IRESSAr) in Patients with Recurrent Malignant Gliomas

Presenter: Chen, Changhu

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos


Authors:
C. Chen*, D. Damek*, L. E. Gaspar*, K. Lillehei*, D. Raben*, S. Ojemann*, B. Kavanagh*. , University of Colorado Health Sciences Ctr., Aurora, CO,

Author Disclosure:
C. Chen, AstraZeneca Pharmaceuticals, B. Research Grant; Imedex, Inc., D. Speakers Bureau/Honoraria; D. Damek, None; L.E. Gaspar, Genentech, F. Consultant/Advisory Board; K. Lillehei, None; D. Raben, AstraZeneca Pharmaceuticals, B. Research Grant; Imedex, Inc., D. Speakers Bureau/Honoraria; S. Ojemann, None; B. Kavanagh, None.


E-mail a friend about this abstract:
Enter email address:   



Abstracts Main Page | Logout